GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Integra Lifesciences Holdings Corp (FRA:IL3) » Definitions » Total Operating Expense

Integra Lifesciences Holdings (FRA:IL3) Total Operating Expense : €720 Mil (TTM As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Integra Lifesciences Holdings Total Operating Expense?

Integra Lifesciences Holdings's Total Operating Expense for the three months ended in Mar. 2024 was €187 Mil. Integra Lifesciences Holdings's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was €720 Mil.

Integra Lifesciences Holdings Total Operating Expense Historical Data

The historical data trend for Integra Lifesciences Holdings's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integra Lifesciences Holdings Total Operating Expense Chart

Integra Lifesciences Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 714.78 575.12 661.46 690.43 709.03

Integra Lifesciences Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 183.52 179.54 179.67 174.64 186.64

Integra Lifesciences Holdings Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €720 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integra Lifesciences Holdings Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Integra Lifesciences Holdings's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Integra Lifesciences Holdings (FRA:IL3) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Integra Lifesciences Holdings Corp (FRA:IL3) » Definitions » Total Operating Expense
Comparable Companies
CNMD RXST NVCR UFPT IRTC SINT QDEL INMD NARI ESTA ABT SYK BSX MDT XTER:SHL EW DXCM SZSE:300760 XAMS:PHIA ZBH
Traded in Other Exchanges
IART:USA
Address
1100 Campus Road, Princeton, NJ, USA, 08540
Website
https://www.integralife.com
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman specialty surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.

Integra Lifesciences Holdings (FRA:IL3) Headlines

No Headlines